Search results for: cmt
Ink & Impact: CMT Stories in Print 2
Ink & Impact: CMT Stories in Print
Disability for CMT Peripheral Neuropathy: VA & Social Security
How likely are people with CMT to get Social Security disability benefits the first time...
CMTA Welcomes Catie Coman as Chief Marketing Officer
CMTA welcomes Catie Coman as Chief Marketing Officer, bringing more than 15 years of experience in patient advocacy to lead marketing and communications strategy.
ENCell Announces Phase 1b/2a Stem Cell Trial for CMT1A
Could stem cells change the path of CMT research? ENCell announces stem cell clinical trial for CMT1A.
2025 CMTA Patient & Research Summit
Saturday Welcome Address Sue Bruhn, PhD IU Health CMT Clinic Team Laurie Gutmann, MD Meet...
How the CMT2C Community Is Driving the Path to Treatment
How is the CMT2C community helping move research forward? A CMTA-hosted focus group on how patient voices are shaping the path to a treatment.
CMTA Invests $281,339 to Advance Treatments for CMT1A
The newly funded study will test whether molecules originally in development as cancer therapeutics can also be used to lower PMP22 and improve nerve health in a model of CMT1A.
